Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abuse, addiction, AE, aforementioned, aim, ambulate, ambulatory, animal, baseline, bipolar, Britain, Canada, cancelled, children, CI, encephalopathy, epileptic, estate, fall, fatigue, GABAA, Gait, genotype, Great, hoc, hyperexcitable, Hyperimmune, introduced, irrevocably, latency, lesion, leveraging, lieu, LS, meaningful, methyltransferase, Mimic, mood, neuropathic, nominal, Notably, nusinersen, onasemnogene, overcome, payoff, PDUFA, pharmacology, physiology, poor, post, Real, rebate, reevaluated, risdiplam, side, similarly, solution, somatosensory, somnolence, spectrum, SpinCo, stable, struggle, subtype, supplemental, TRP, unbiased, uncontrolled, Union, unissued, untreated, User, Vehicle, walk, window, withdrawn, withholding
Removed:
AD, Alzheimer, biologic, biomarker, contact, Cooperative, cure, decision, Dementia, differentiate, distribute, exhibited, fast, hippocampal, imaging, informative, magnetic, MRI, neutralizing, nonclinical, nonsignificant, occurrence, participate, pharmacokinetic, prespecified, realization, registrational, resonance, revealed, spinocerebellar, spread, Subscale, volumetric, warranted
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view